Electromagnetic Therapy for Cervicogenic Dysphagia
Efficacy of Electromagnetic Therapy in the Treatment of Cervicogenic Dysphagia: Randomized Single-blind Placebo-Control Study
1 other identifier
interventional
40
1 country
1
Brief Summary
Cervicogenic dysphagia (CD) is a swallowing disorder in patients with cervicogenic pathology. Pulsed electromagnetic therapy (PEMT) is a widely utilized therapeutic modality. Objective: To investigate the effects of PEMT on swallowing function (SF) and dysphagia handicapping effects in patients with CD. Methods: 40 volunteer participants (50-60 years old) with CD and cervical spondylosis were randomly and equally assigned to the study group (PEMT+swallowing resistance training program "SRTP") and control group (placebo PEMT+SRTP). Intervention: All participants received 3 sessions of SRTP (resisted chin tuck-in and resisted swallowing exercises) and 2 PEMT sessions (20 minutes of 20 Hz low frequency, 0.8 milli Tesla low intensity) per week for 8 weeks. Outcome Measures: The SF was evaluated using the swallow difficulty questionnaire "SDQ", and the dysphagia handicapping effects were evaluated using the dysphagia handicap index (DHI) pre-and post-study. Statistical analysis: Within-group comparisons were done using a paired t-test, and the between-group differences were examined using two-way ANOVA; a significant value was set at P\<0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2026
CompletedFirst Submitted
Initial submission to the registry
August 10, 2026
CompletedFirst Posted
Study publicly available on registry
August 14, 2026
CompletedAugust 14, 2026
August 1, 2026
9 months
August 10, 2026
August 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Swallowing function
Assessment of the swallowing function using the Swallowing Disturbance Questionnaire, composed of 15 self-reported items.
Baseline and post-8 weeks
The dysphagia handicapping effects
The dysphagia handicapping effects assessment (using Dysphagia Handicap Index)
Baseline and post 8 weeks.
Secondary Outcomes (2)
Pain intensity
Baseline and post 8 weeks
The forward head position
Baseline and post 8 weeks
Study Arms (2)
Study group (received PEMFT + swallowing resistance training program; n=20)
EXPERIMENTALParticipants in the study group received the PEMFT treatment program in addition to the swallowing resistance training program "SRTP (which included the resisted chin tuck-in and the resisted swallowing exercises).
Control group (received placebo PEMFT + swallowing resistance training program; n=20)
PLACEBO COMPARATORParticipants in the control (Placebo comparator) group received the placebo PEMFT treatment program in addition to the swallowing resistance training program "SRTP (which included the resisted chin tuck-in and the resisted swallowing exercises).
Interventions
The pulsed electromagnetic field treatment program plus the swallowing resistance training program
The placebo pulsed electromagnetic field treatment program plus the swallowing resistance training program
Eligibility Criteria
You may qualify if:
- Individuals diagnosed with cervicogenic dysphagia and cervical spondylosis, aged 50-60 years, with a sedentary lifestyle (less than 30 minutes of aerobic activities per day), and who signed the written consent
You may not qualify if:
- Subjects diagnosed with rheumatological disease, cerebrovascular abnormalities, having a metal implant or previous cervical surgeries, or having received any physical therapy programs for cervical spondylosis or dysphagia within the last 6 months. Subjects with recent infection, cognitive impairments or dementia, cardiovascular instability, head or neck traumatic injuries, neurological disorders affecting swallowing (e.g., parkinsonism, stroke), those who received medications interfering with normal swallowing function (e.g., antiepileptics, antipsychotics, and antidepressant drugs), and subjects who refused to provide the signed informed consent were all excluded at the beginning of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Umm Al-Qura University
Mecca, 24351, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ASHRAF AM ABDELAAL, Ph.D.
Umm Al-Qura University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- This study followed the pre-posttest, randomized, single-blind, parallel arm, placebo-controlled study design. All participants were blind to the PEMFT treatment (participants were not oriented towards the PEMFT, whether actual or placebo); assessors were blind to the groups' allocation and the received treatment, groups' allocation and study design.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 10, 2026
First Posted
August 14, 2026
Study Start
July 1, 2025
Primary Completion
March 20, 2026
Study Completion
May 25, 2026
Last Updated
August 14, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Required Institutional Ethical Committee approval first.